Shannon Meeks

13PUBLICATIONS
41CO-AUTHORS
HaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyHealth equityMicrofluidics and nanofluidics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Dec 16, 2024
Bleed treatment with eptacog beta (rFVIIa) results in a low incidence of rebleeding in adult and adolescent patients with haemophilia A or B with inhibitors.

Amy Dunn, Yesim Dargaud, Yasmina Abajas

|Nov 25, 2024
Rescue immune tolerance induction with a recombinant factor Fc-fused VIII: prospective ReITIrate study of clinical, humoral and cellular immune responses.

Christoph Königs, Shannon L Meeks, Beatrice Nolan

|Mar 28, 2024
Haemophilia in the era of novel therapies: Where do inhibitors feature in the new landscape?

Shannon L Meeks, Karen L Zimowski

|Mar 15, 2023
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophilia.

Duc Q Tran, Craig C Benson, Judith A Boice

|Mar 11, 2023
Qualification of Hemophilia Treatment Centers to Enable Multi-Center Studies of Gene Expression Signatures in Blood Cells from Pediatric Patients.

Birgit M Reipert, Christoph J Hofbauer, Bagirath Gangadharan

|Apr 27, 2022
Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors.

Steven W Pipe, Cédric Hermans, Meera Chitlur

Pageof 3

Frequent Collaborators

3 joint publications

Pete Lollar

2 joint publications

Glaivy Batsuli

2 joint publications

Guy Young

2 joint publications

Johnny Mahlangu